Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome.
Falkenberg, Virginia R, Whistler, Toni, Murray, Janna R et al. · Genetics & epigenetics · 2013 · DOI
Quick Summary
This study looked at how a stressful situation affects a type of immune cell protein called perforin in people with ME/CFS versus healthy people. Researchers gave both groups a stress test and measured changes in perforin levels and a chemical modification (methylation) that controls whether genes are turned on or off. They found that while both groups increased perforin during stress, people with ME/CFS had a lower peak response and differently regulated perforin levels afterward.
Why It Matters
Understanding how stress affects immune cell function and gene regulation in ME/CFS could help explain why patients often experience worsening symptoms after stress or exertion. This research provides insight into epigenetic mechanisms—chemical switches controlling genes—that may differ in ME/CFS, potentially pointing toward new diagnostic or therapeutic targets.
Observed Findings
Both CFS and non-fatigued groups showed 1.6-fold increase in perforin expression during the Trier Social Stress Test (P=0.0003 for CFS, P<0.0001 for non-fatigued).
CFS participants had a significantly lower peak perforin response immediately following the stress test compared to non-fatigued controls (P=0.04).
At 1.5 hours post-stress, perforin expression was elevated in CFS compared with non-fatigued subjects (whole blood P=0.06, PBMC P=0.02).
Perforin promoter methylation at 7 CpG sites ranged from 38-79% and showed significant negative correlation with PRF1 expression in both groups (CFS r=-0.56, non-fatigued r=-0.38, both P<0.0001).
Among participants with high methylation (≥65%), perforin expression was significantly lower in CFS than non-fatigued subjects immediately post-stress.
Inferred Conclusions
Methylation of the perforin promoter is an important epigenetic regulator of inter-individual differences in perforin expression across both CFS and non-fatigued populations.
The acute stress response pattern of perforin expression differs between CFS and non-fatigued individuals, particularly in the immediate post-stress period and recovery phase.
CFS may be associated with altered epigenetic regulation of perforin during acute psychosocial stress, particularly in individuals with higher baseline promoter methylation.
Remaining Questions
What This Study Does Not Prove
This study does not prove that abnormal perforin regulation causes ME/CFS or that stress causes the illness. The findings are correlational and from acute stress responses in a lab setting; they do not establish whether these patterns relate to symptom severity, disease progression, or would persist in real-world chronic stress. The similar baseline PRF1 expression between groups contradicts some prior reports and requires replication.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does the altered perforin expression pattern in CFS acute stress responses relate to symptom severity, post-exertional malaise, or the characteristic symptom worsening after physical or cognitive activity?
What causes the differences in perforin methylation between individuals, and are these methylation patterns stable over time or do they change with stress exposure?
Do these acute stress-induced perforin changes reflect or contribute to the chronic immune dysfunction observed in ME/CFS, or are they separate phenomena?
How do these findings relate to infection history and the proposed infectious triggers of ME/CFS?